Tumor Profiling in Non-Small Cell Lung Cancer
With our advanced platform of Tumor Profiling to Guide Targeted Cancer Therapy, Creative Biolabs has developed an unparalleled platform for non-small cell lung tumor profiling. To fulfill every need of our consumers, our professional scientists are ready to start working on your projects.
Introduction of Non-Small Cell Lung Cancer (NSCLC) Tumor Profiling
NSCLC is the most prevalent type of lung cancer, which is the first leading category of cancer worldwide. Nowadays, personalized therapies have provided more efficient treatment options than traditional therapies, along with which the optimal treatment identification has become progressively intricate. A comprehensive tumor profiling in NSCLC could improve the therapeutic effectiveness and avoid useless effort.
Fig.1 Modern tumor profiling in lung cancer. (Cancer Genome Atlas Research Network, 2014)
Tumor Profiling in NSCLC at Creative Biolabs
Recent advances in Technologies for Tumor Profiling have provided us insight into the heterogeneity among NSCLC tumor cell populations. We provide the tumor Profiling in different biomarker expression levels with different techniques.
Technologies with tissue dissociation or liquid biopsy
→
-
NGS (Next-generation Sequencing)
-
PCR (Polymerase Chain Reaction)
-
Flow Cytometry
-
Microarray
Technologies with spatial processing
→
-
FISH (In Situ Hybridization)
-
IHC (Immunohistochemistry)
-
IF (Immunofluorescence)
-
List of some biomarkers of tumor profiling in NSCLC
-
Workflow for tumor profiling in NSCLC
On-machine Detection
Data Interpretation
Sample Pretreatment
Data Acquisition
Provide report
Features of Tumor Profiling in NSCLC at Creative Biolabs
Creative Biolabs is a world-leading services provider in the field of tumor profiling. Equipped with advanced platforms and powerful technologies, our services team is expertise and dedicated to supporting heterogeneous tumor profiling demands by developing this high-quality platform. If you are interested in our services, please contact us directly.
Reference
-
Cancer Genome Atlas Research Network, Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014, 511(7511): 543.
For Research Use Only | Not For Clinical Use